NCT06064305

Transcriptional and Proteomic Analysis of Acute Kidney Injury

Name: Clinical Trial NCT06064305
Creator: University Hospital Muenster
Keywords: Acute Kidney Injury, No study-specific interventions, other, clinical trial

University Hospital Muenster·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Acute Kidney Injury
Drug/Device/Intervention: No study-specific interventions
Study type: Observational
Intervention type: other

Sponsor & location

Primary sponsor: University Hospital Muenster

Timeline & enrollment

Phase: N/A
Start date: Sep 29, 2023
End date: Dec 01, 2024
Enrollment: 60 participants

Primary outcome

Correlation of transcriptional and proteomic gene regulation in tissue with clinical molecular Imaging and AKI biomarkers.

Summary

Acute kidney injury is associated with worsened outcome for critically ill patients. Sepsis-associated and non-septic cardiothoracic surgery associated AKI have been reported, nonetheless, precise pathomechanistic differences as well as detectability of transcriptional and proteomic changes in correlation with imaging and plasma markers are unclear.

ICD-10 classifications

Injury of kidneyAcute renal failureAcute renal failure, unspecifiedOther acute renal failureAcute renal failure with tubular necrosis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06064305
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06064305 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Muenster and is currently Not yet recruiting. The study focuses on Acute Kidney Injury. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.